Combined Compared to Sequential Cognitive and Physical Training in Anterior Cruciate Ligament Reconstructed Individuals

NCT06845150 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2025-12-08

No results posted yet for this study

Summary

The goal of this clinical trial is to investigate changes in cognitive and physical performance after 10 weeks of dual or single task training in anterior cruciate ligament (ACL) reconstructed individuals. The main questions it aims to answer are:

* Does cognitive performance in ACL reconstructed individuals change after multiple training sessions incorporating single versus dual-task?
* Does physical performance and intrinsic motivation for training change over the course of 10 weeks when performing single versus dual-task training sessions?
* What movement patterns do ACL reconstructed individuals show during a dual-task training in an immersive environment?

Researchers will compare a combined dual-task training (combined physical and cognitive training) to a single task training (physical and cognitive training separately) to see if there are changes on cognitive performance depending on the training type.

Participants will:

* Perform dual-task or single task training twice per week for 10 weeks
* Visit the clinic before and after the training period for tests
* Visit the movement laboratory once for analysis of movement patterns

Conditions

  • Anterior Cruciate Ligament Reconstruction Rehabilitation

Interventions

OTHER

Dual-task training

Combined simultaneous physical and cognitive training in an immersive environment

OTHER

Single task training

Sequential cognitive and then physical training

Sponsors & Collaborators

  • Kantonsspital Winterthur KSW

    collaborator OTHER
  • ZHAW DIZH Fellowship Program

    collaborator UNKNOWN
  • Michelle C. Haas

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-05
Primary Completion
2025-06-12
Completion
2025-10-08

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06845150 on ClinicalTrials.gov